Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

BGI-Shenzhen Closes $118 Million Acquisition of Complete Genomics

publication date: Mar 19, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BGI-Shenzhen, the world’s largest gene sequencing company, closed its $118 million acquisition of Complete Genomics. Complete Genomics is a Silicon Valley company that specializes in whole human genome sequencing. BGI purchased all of Complete's outstanding common shares at $3.15 each, and it will operate Complete as a wholly-owned subsidiary. Dr. Clifford Reid will remain its CEO. Note: ChinaBio® recently interviewed Jun Wang, PhD, CEO of BGI, who talked about the Complete acquisition and other matters. The interview is available here. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors